Rein Therapeutics RNTX
NASDAQ RNTX
$0.80 -0.05 (-5.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Sales of Property, Plant and Equipment (2020)

Updated

Rein Therapeutics' Sales of Property, Plant and Equipment was $42,000 in FY2023.

Analysis

Rein Therapeutics (RNTX) Sales of Property, Plant and Equipment (2020) Analysis & Trends

  • Sales of Property, Plant and Equipment shows a three-year compound annual growth rate of -41.3% (FY2020 to FY2023).
  • Per Business Quant data, Sales of Property, Plant and Equipment in earlier years was $66,000 in FY2021 (-68.3%) and $208,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Rein Therapeutics 53.67 Mn 53.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 142,000.00
Mar 31, 2020 66,000.00
API Access

Rein Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=RNTX&period=max&api_key=YOUR_API_KEY